Brief: F.D.A. Grants Early Access To Revolution Medicines Promising Drug Daraxonrasib For Pancreatic Cancer - NYT
01/05/2026 16:45
May 1 (Reuters) - F.D.A. GRANTS EARLY ACCESS TO PROMISING DRUG FOR PANCREATIC CANCER - NYT F.D.A. GRANTS EARLY ACCESS TO REVOLUTION MEDICINES PROMISING DRUG DARAXONRASIB FOR PANCREATIC CANCER - NYT Source text: https://tinyurl.com/y4ys3yy4 Further company coverage: RVMD.O ((Reuters.briefs@thomsonreuters.com;))
Recent news on Revolution Medicines
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
Brief: CHMP Recommends Granting Marketing Authorisation For Rasonque For Metastatic Pancreatic Cancer In EU
Revolution Medicines wins EU committee backing for pancreatic cancer treatment (updated)
EMA recommends approval of Revolution's pancreatic cancer drug
Revolution Medicines falls on pancreatic cancer drug data concerns